Frederick Sanger

Frederick Sanger
Born	Frederick Sanger 13 August 1918
Birthplace	Rendcomb, Gloucestershire, England
Died	19 November 2013 Cambridge, England
Nationality	British
Occupation	Biochemist
Known for	Protein sequencing (insulin), DNA sequencing (Sanger method), two-time Nobel laureate in Chemistry
Education	St John's College, Cambridge (BA, PhD)
Spouse(s)	Margaret Joan Howe (m. 1940)
Children	3
Awards	Nobel Prize in Chemistry (1958, 1980), Order of Merit (1986)

Frederick Sanger (13 August 1918 – 19 November 2013) was a British biochemist whose work fundamentally transformed the understanding of biological molecules in the twentieth century. He is one of only four individuals in history to have been awarded the Nobel Prize twice, and the only person to have received the Nobel Prize in Chemistry on two separate occasions — first in 1958 for determining the complete amino acid sequence of insulin, and again in 1980 for developing the first practical method of sequencing DNA. His first achievement established that proteins possess unique, definable chemical structures, a foundational principle for the central dogma of molecular biology. His second — the development of what became known as the Sanger sequencing method — made it possible to read the genetic code of any organism and laid the groundwork for the Human Genome Project and the modern era of genomics. A quiet, self-effacing figure who preferred laboratory work to public attention, Sanger spent virtually his entire career at the University of Cambridge and the Medical Research Council's Laboratory of Molecular Biology, where his meticulous experimental approach yielded discoveries that reshaped the biological sciences.

Early Life

Frederick Sanger was born on 13 August 1918 in the village of Rendcomb in Gloucestershire, England. His father, Frederick Sanger Sr., was a medical doctor who had worked as a medical missionary in China before returning to England to practise as a general practitioner. His mother, Cicely Sanger (née Crewdson), came from a prosperous cotton manufacturing family. Sanger had an older brother, Theodore, and a younger sister, Mary.

Growing up in a comfortably middle-class household, Sanger was exposed to science from an early age through his father's medical practice and through collecting specimens in the Gloucestershire countryside. His father's influence initially directed the young Sanger toward medicine, but it was the natural world and the systematic investigation of its workings that captured his imagination. He later reflected that his father's scientific approach to medicine had instilled in him a respect for careful observation and evidence-based reasoning.

The family were Quakers, and the pacifist values of their faith had a lasting impact on Sanger's worldview. When the Second World War broke out, Sanger registered as a conscientious objector, a decision that was supported by his Quaker upbringing. This status allowed him to continue his studies and research at Cambridge throughout the war years, a circumstance that proved decisive for his career.

As a boy, Sanger attended the Downs School, a preparatory school, and later went to Bryanston School in Dorset. His school years, though not academically distinguished in conventional terms, fostered in him an increasing interest in science, particularly chemistry and biology. He found that he was drawn to the practical, experimental side of these subjects rather than to theoretical work — a preference that would define his entire scientific career.

Education

Sanger entered St John's College, Cambridge, in 1936, initially intending to study medicine as his father had done. However, he soon found that his interests lay more in the natural sciences, and he switched to studying biochemistry — at that time a relatively young and small discipline at Cambridge. He completed his Bachelor of Arts degree in 1939.

Remaining at Cambridge after his undergraduate studies, Sanger pursued doctoral research under the supervision of Albert Neuberger. His PhD thesis, completed in 1943, was entitled "The metabolism of the amino acid lysine in the animal body," a project that introduced him to the biochemistry of amino acids and proteins — the area that would define the first phase of his career. His conscientious objector status during the war meant he was able to remain at Cambridge without interruption, and the relative quiet of the wartime laboratory afforded him time to develop the patient, methodical working habits that would characterise his later achievements.

Career

Protein Sequencing and the Structure of Insulin

After completing his PhD in 1943, Sanger remained at Cambridge, where he joined the laboratory of Albert Chibnall, who had recently been appointed Professor of Biochemistry. Chibnall suggested that Sanger investigate the chemical structure of insulin, a protein hormone that was readily available in purified form and of obvious medical importance. At the time, it was not known whether proteins had definite chemical sequences or whether they were amorphous mixtures of amino acids. The prevailing view among many chemists was that proteins might not have precise, reproducible structures at all.

Sanger's approach was to develop methods to break insulin into smaller fragments and then determine the order of amino acids in each fragment. He devised a chemical reagent — 1-fluoro-2,4-dinitrobenzene (later known as Sanger's reagent) — that could label the free amino group at the end of a peptide chain, allowing him to identify the terminal amino acid after breaking the chain apart. By applying this technique systematically to overlapping fragments of the insulin molecule, he was able to piece together the complete amino acid sequence of both the A chain and the B chain of bovine insulin.

This work, carried out over approximately a decade from the mid-1940s to the mid-1950s, was painstaking in its detail. Sanger and his collaborators used a combination of partial acid hydrolysis, enzymatic digestion, and paper chromatography to separate and identify the peptide fragments. The complete sequence of insulin's 51 amino acids was published in 1955, representing the first time the full amino acid sequence of any protein had been determined.

The significance of this achievement was enormous. By demonstrating that insulin had a specific, unique amino acid sequence, Sanger established the principle that all proteins have definite chemical structures encoded in their genes. This finding was a critical piece of evidence for the emerging central dogma of molecular biology — the idea that genetic information flows from DNA to RNA to protein in a predictable, sequence-dependent manner. For this work, Sanger was awarded the Nobel Prize in Chemistry in 1958, the sole recipient that year.

Move to the Laboratory of Molecular Biology

In 1962, Sanger moved to the newly established Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) in Cambridge, a purpose-built facility that brought together some of the most distinguished molecular biologists in the world, including Francis Crick, James Watson, Max Perutz, and John Kendrew. The LMB provided Sanger with the resources and intellectual environment to shift his focus from proteins to nucleic acids — the molecules that carry genetic information.

The transition was not immediate. Sanger initially worked on sequencing RNA molecules, developing techniques to determine the nucleotide sequences of small RNA species. This work served as a bridge between his earlier protein sequencing and his later DNA sequencing efforts, as it required him to adapt his fragment-based approach to a new type of biological polymer.

Development of DNA Sequencing

The development of a practical method for sequencing DNA became Sanger's central preoccupation through the 1970s, and it culminated in the technique that bears his name. The method, published in 1977, is formally known as the chain-termination method or dideoxy sequencing method. It relies on the use of modified nucleotides — dideoxynucleotides — that lack the 3' hydroxyl group necessary for the formation of phosphodiester bonds. When incorporated into a growing DNA strand by DNA polymerase, these modified nucleotides cause the chain to terminate at specific, known positions. By running four separate reactions, each containing a different dideoxynucleotide (corresponding to each of the four DNA bases: A, T, G, and C), and then separating the resulting fragments by gel electrophoresis, the sequence of the DNA could be read directly from the gel.

The elegance and reliability of the Sanger method made it the dominant DNA sequencing technology for over three decades. It was used to sequence the first complete genome of a free-living organism (the bacterium Haemophilus influenzae in 1995), the first eukaryotic genome (the yeast Saccharomyces cerevisiae in 1996), and most significantly, the human genome, completed in draft form in 2000 and finished in 2003. While so-called "next-generation" sequencing technologies have since supplemented and in many contexts replaced the original Sanger method, the chain-termination approach remains in use for targeted sequencing applications and as a gold-standard validation tool.

One of the first major applications of the Sanger method was the sequencing of the entire genome of bacteriophage φX174, a virus that infects bacteria. Completed in 1977, this 5,386-nucleotide sequence was the first complete DNA genome ever determined, a milestone in the history of biology.

Sanger subsequently turned his attention to larger genomes. In 1981, he and his collaborators published the complete 16,569-base-pair sequence of the human mitochondrial genome, demonstrating the feasibility of sequencing complex, biologically significant DNA molecules. This achievement further established the power and versatility of his sequencing method.

Sequencing RNA

Before developing the DNA chain-termination method, Sanger also made significant contributions to RNA sequencing. In the late 1960s and early 1970s, he developed methods for determining the nucleotide sequences of ribosomal RNA and other small RNA molecules. These techniques involved enzymatic digestion and two-dimensional fractionation of the resulting oligonucleotides — an approach conceptually similar to the fragment-overlap strategy he had used for protein sequencing. While the RNA sequencing methods were ultimately superseded by the more powerful DNA-based approaches, they provided important structural information about ribosomal RNA and helped refine Sanger's experimental thinking as he moved toward the DNA problem.

Retirement

Sanger retired from active research in 1983, at the age of 65. He later explained that he felt he had accomplished what he set out to do and that the techniques he had developed were now in the hands of younger scientists who could apply them more effectively to the rapidly expanding questions of molecular biology. After retirement, he largely withdrew from public scientific life, declining most invitations to speak or to lend his name to campaigns. He spent his retirement years in Cambridge, devoting time to gardening and other personal interests.

In a 2001 interview, Sanger reflected on the nature of scientific research and the role of chance and persistence in experimental work. He characterised himself as someone who preferred practical laboratory work to theoretical speculation, and he attributed much of his success to the willingness to spend long periods refining techniques until they yielded reliable results.

Personal Life

Sanger married Margaret Joan Howe in 1940. The couple had three children. Margaret Sanger (née Howe) was an economist by training. The family lived in Cambridge for the duration of Sanger's career, and Sanger maintained a quiet, private domestic life that stood in contrast to the magnitude of his scientific contributions.

Sanger's Quaker faith remained a significant part of his personal identity. His conscientious objection during the Second World War was a direct expression of his religious convictions, and the values of simplicity, honesty, and modesty that characterise Quaker life were reflected in his personal demeanour. He was noted by colleagues and friends for his unassuming manner and his reluctance to seek public recognition or celebrity.

His first cousin, Ruth Sanger, was also a notable scientist who made important contributions to the study of human blood groups.

Sanger declined a knighthood, reportedly because he did not wish to be addressed as "Sir." He did, however, accept appointment to the Order of Merit in 1986, one of the highest honours in the British honours system, limited to 24 living members at any one time.

Frederick Sanger died on 19 November 2013 at Addenbrooke's Hospital in Cambridge, at the age of 95.

Recognition

Sanger's two Nobel Prizes in Chemistry — awarded in 1958 and 1980 — place him in an extraordinarily select group. He is one of only four individuals to have won two Nobel Prizes, and the only person to have received both awards in chemistry. The other two-time Nobel laureates are Marie Curie (Physics 1903, Chemistry 1911), Linus Pauling (Chemistry 1954, Peace 1962), John Bardeen (Physics 1956, Physics 1972), and Karl Barry Sharpless (Chemistry 2001, Chemistry 2022).

The 1958 Nobel Prize was awarded to Sanger alone "for his work on the structure of proteins, especially that of insulin." The 1980 Nobel Prize in Chemistry was shared between Sanger and Walter Gilbert "for their contributions concerning the determination of base sequences in nucleic acids," with the other half going to Paul Berg "for his fundamental studies of the biochemistry of nucleic acids, with particular regard to recombinant-DNA."

Beyond the Nobel Prizes, Sanger received numerous other honours during his career. He was elected a Fellow of the Royal Society in 1954. He received the Commander of the Order of the British Empire (CBE) in 1963 and was appointed to the Order of Merit in 1986. He was also awarded the Copley Medal of the Royal Society, one of the oldest and most prestigious scientific awards in the world.

The Wellcome Trust Sanger Institute (now the Wellcome Sanger Institute), located near Cambridge at the Hinxton campus, was named in his honour. The institute, established in 1992, became one of the primary centres for the Human Genome Project and remains a leading centre for genomic research.

Sanger was also named an inaugural Fellow of the American Association for Cancer Research (AACR) Academy.

Legacy

Frederick Sanger's contributions to science are measured not only in the specific discoveries he made but in the vast fields of inquiry his methods opened to subsequent generations of researchers. His sequencing of insulin proved that proteins have defined, reproducible structures — a finding without which the modern understanding of enzymology, drug design, and molecular medicine would not exist. His DNA sequencing method enabled the reading of genetic code on a scale that was previously unimaginable, making possible the fields of genomics, pharmacogenomics, and personalised medicine.

The Sanger sequencing method served as the technological backbone of the Human Genome Project, the largest collaborative biological project ever undertaken, which produced the first essentially complete sequence of the human genome. The completion of this project in 2003 inaugurated an era in which genetic information became a central tool of biomedical research, clinical diagnosis, and public health. While newer sequencing technologies have since been developed, many of them were designed to overcome specific limitations of the Sanger method, and the conceptual framework of reading DNA sequences base by base owes its origins to his work.

Sanger's approach to science — characterised by meticulous experimental work, the development of new methods rather than the application of existing ones, and a focus on technically difficult problems — served as a model for generations of biochemists and molecular biologists. Many of his former students and postdoctoral researchers went on to become leaders in their own fields. His laboratory at the LMB was known as a place where practical skill and methodological innovation were valued above theoretical elegance.

Nature, in its obituary, described Sanger as "the father of genomics," reflecting the centrality of his sequencing methods to the entire discipline. The Wellcome Sanger Institute continues to bear his name and carries forward his legacy through large-scale genomic research projects that build directly on the foundations he established.

Sanger's modesty and reluctance to seek the public spotlight, unusual for a scientist of his stature, became part of his reputation. He famously described himself as "just a chap who messed about in his lab," a characterisation that, while self-deprecating, captured something essential about his conviction that the work itself mattered more than the recognition it attracted.